Lipidor
Less than 1K followers
All
Press releases
ShowingAll content types
Lipidor announces today negative results from the company's Phase III clinical study of AKP02G2 for psoriasis
Lipidor announces database lock in its Phase III clinical study of the psoriasis candidate AKP02G2
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools